Journal article
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
- Abstract:
-
PURPOSE: The prognosis of HIV-infected patients with non-Hodgkin lymphoma in the highly active antiretroviral therapy (HAART) era approaches that of the general population when they are treated with the same protocols. We analyzed the outcome of patients with Hodgkin lymphoma (HL) treated with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) in the HAART era according to HIV serostatus to establish whether this also holds true for HL. PATIENTS AND METHODS: From 1997 to 2010, 224 p...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Volume:
- 30
- Issue:
- 33
- Pages:
- 4111-4116
- Publication date:
- 2012-11-01
- DOI:
- EISSN:
-
1527-7755
- ISSN:
-
0732-183X
- Source identifiers:
-
354210
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:354210
- UUID:
-
uuid:67816227-0d57-4ec4-b87b-2098d6ed6f20
- Local pid:
- pubs:354210
- Deposit date:
- 2013-11-17
Terms of use
- Copyright date:
- 2012
If you are the owner of this record, you can report an update to it here: Report update to this record